Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.00 GBX | +8.33% | +8.33% | +18.18% |
12-11 | RUA Life Sciences swings to pretax profit in its first half | AN |
12-11 | Earnings Flash (RUA.L) RUA LIFE SCIENCES Posts Fiscal H1 Revenue GBP1.5M | MT |
Capitalization | 8.07M 9.84M 9.56M 8.99M 14.17M 852M 15.83M 110M 40.67M 350M 36.88M 36.13M 1.54B | P/E ratio 2025 * |
-8.13x | P/E ratio 2026 * | 18.6x |
---|---|---|---|---|---|
Enterprise value | 4.97M 6.06M 5.88M 5.54M 8.72M 524M 9.75M 67.61M 25.05M 215M 22.71M 22.25M 947M | EV / Sales 2025 * |
1.52x | EV / Sales 2026 * | 1x |
Free-Float |
46.64% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: RUA Life Sciences plc
1 day | +8.33% | ||
1 week | +8.33% | ||
Current month | +18.18% | ||
1 month | +18.18% | ||
3 months | -8.77% | ||
6 months | +18.18% | ||
Current year | +18.18% |
Director | Title | Age | Since |
---|---|---|---|
Bill Brown
CEO | Chief Executive Officer | 56 | 18/06/2024 |
Lachlan Smith
DFI | Director of Finance/CFO | - | 30/11/2021 |
John McKenna
CEO | Chief Executive Officer | 72 | 30/10/2016 |
Manager | Title | Age | Since |
---|---|---|---|
John McKenna
BRD | Director/Board Member | 72 | 30/10/2016 |
John Ely
BRD | Director/Board Member | 74 | - |
Chairman | 69 | 18/06/2024 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+8.33% | +8.33% | +3.17% | -79.20% | 9.84M | ||
-0.37% | +3.20% | +3.78% | -5.91% | 214B | ||
+1.47% | +8.25% | +65.14% | +92.58% | 211B | ||
-1.46% | +1.40% | +6.14% | -18.73% | 172B | ||
+0.50% | +3.98% | +61.84% | +119.93% | 145B | ||
+2.24% | +1.28% | -0.84% | -12.46% | 60.06B | ||
+1.82% | +7.19% | +15.02% | +1.85% | 42.09B | ||
-0.11% | -4.96% | -5.47% | -40.99% | 41.16B | ||
-0.31% | -0.02% | +16.48% | - | 38.72B | ||
-0.29% | +1.23% | -13.23% | -30.59% | 38.61B | ||
Average | +1.18% | +2.91% | +15.20% | +2.94% | 96.34B | |
Weighted average by Cap. | +0.24% | +3.59% | +26.05% | +31.31% |
2025 * | 2026 * | |
---|---|---|
Net sales | 3.26M 3.97M 3.86M 3.63M 5.72M 344M 6.39M 44.35M 16.43M 141M 14.9M 14.59M 621M | 4.27M 5.21M 5.06M 4.76M 7.51M 451M 8.38M 58.17M 21.55M 185M 19.54M 19.14M 814M |
Net income | -992K -1.21M -1.18M -1.11M -1.74M -105M -1.95M -13.5M -5M -43M -4.54M -4.44M -189M | 435K 530K 515K 485K 764K 45.92M 853K 5.92M 2.19M 18.86M 1.99M 1.95M 82.88M |
Net Debt | -3.1M -3.78M -3.67M -3.45M -5.44M -327M -6.08M -42.19M -15.63M -134M -14.17M -13.88M -591M | -3.8M -4.63M -4.5M -4.23M -6.67M -401M -7.45M -51.72M -19.16M -165M -17.37M -17.02M -724M |
Date | Price | Change | Volume |
---|---|---|---|
17/01/25 | 13.00 p | +8.33% | 291,527 |
16/01/25 | 12.00 p | 0.00% | 302,184 |
15/01/25 | 12.00 p | 0.00% | 48,679 |
14/01/25 | 12.00 p | 0.00% | 42,932 |
13/01/25 | 12.00 p | 0.00% | 183,413 |
Delayed Quote London S.E., January 17, 2025 at 04:35 pm
More quotesAnnual profits - Rate of surprise
- Stock Market
- Equities
- AOR Stock
MarketScreener is also available in this country: United States.
Switch edition